B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

POLL

MOLECULAR TARGET

DNA polymerase lambda

UniProt: Q9UGP5NCBI Gene: 273433 compounds

POLL (DNA polymerase lambda) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting POLL

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1oblongifolin c2.087
2guttiferone k1.795
3juglone hydroxylase [Supplementary Concept] catalyzes1.102

About POLL as a Drug Target

POLL (DNA polymerase lambda) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented POLL interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

POLL inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.